Asia’s healthcare market has remained resilient amid broader market volatility, driven by rising demand, demographic tailwinds, and unmet medical needs. With deal activity accelerating across China, India, Southeast Asia, and the Middle East, how are private equity investors identifying scalable opportunities across hospital networks, medtech, and digital health? What makes healthcare one of the most durable, high-conviction bets in the region?
